Convertible Notes (Details Narrative) - USD ($)
|
12 Months Ended |
|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
| Accrued interest |
$ 397
|
|
|
| Shares of common stock |
137,996
|
|
|
| Convertible notes payable, net of debt discount |
$ 0
|
$ 103,920
|
|
| Debt instrument, conversion of shares |
597,139
|
|
|
| Common stock value for service provider |
$ 0
|
|
|
| Accrued compensation |
45,000
|
|
|
| Loan Balance |
298,778
|
|
|
| Debt instrument, principal balance |
295,000
|
205,000
|
|
| Beneficial conversion feature |
234,912
|
909,565
|
|
| Legal Counsel [Member] |
|
|
|
| Accrued compensation |
3,569
|
$ 45,000
|
|
| Debt instrument, principal balance |
175,000
|
|
|
| Maturity Date |
|
Mar. 31, 2021
|
|
| Debt instrument debt discount |
|
$ 45,000
|
|
| Price per share |
|
$ 0.50
|
|
| Interest Rate |
|
3.00%
|
|
| Beneficial conversion feature |
|
$ 45,000
|
|
| Common stock value for service provider |
$ 176,502
|
|
|
| Debt instrument, conversion of shares |
350,000
|
557,056
|
|
| Interest Expense |
$ 1,502
|
$ 1,537
|
$ 0
|
| Two Unaffiliated Individuals [Member] |
|
|
|
| Maturity Date |
Jun. 30, 2021
|
|
|
| Price per share |
$ 0.85
|
|
|
| Interest Rate |
3.00%
|
|
|
| Beneficial conversion feature |
$ 32,412
|
|
|
| Interest Expense |
32,412
|
|
|
| Proceeds from convertible notes payable |
115,000
|
|
|
| Medical advisor [Member] |
|
|
|
| Convertible notes payable, net of debt discount |
115,000
|
103,920
|
|
| Accrued compensation |
90,000
|
|
|
| Debt instrument, principal balance |
$ 90,000
|
205,000
|
|
| Accrued compensation, convertible notes |
|
$ 205,000
|
|
| Maturity Date |
Mar. 31, 2021
|
Mar. 31, 2021
|
|
| Debt instrument debt discount |
$ 90,000
|
$ 101,080
|
|
| Price per share |
$ 0.50
|
$ 0.50
|
|
| Lower price per share |
0.85
|
|
|
| Unamortized debt discount |
$ 0
|
|
|
| Interest Rate |
3.00%
|
3.00%
|
|
| Amortization debt discount |
$ 191,080
|
|
|
| Beneficial conversion feature |
$ 90,000
|
$ 90,000
|
|